Siren Biotechnology ITM Trademark for Gene Therapy
Summary
USPTO published Siren Biotechnology's intent-to-use trademark application for the stylized mark 'SIREN BIOTECHNOLOGY' covering pharmaceutical preparations for gene therapy for cancer treatment and related research and development services. The application (TM99737013) was filed on March 31, 2026, with an Intent-to-Use filing basis indicating the applicant has not yet used the mark in commerce but intends to do so.
What changed
Siren Biotechnology filed an Intent-to-Use trademark application with USPTO for its stylized company name covering Class 5 pharmaceutical preparations for gene therapy targeting cancer treatment, as well as research and development services in the pharmaceutical and biotechnology fields. The application (TM99737013) was filed on March 31, 2026.
Trademark applicants and competitors in the gene therapy and oncology pharmaceutical space should review the application to identify potential conflicts with existing marks. No immediate compliance actions are required from most regulated entities. This filing does not create new regulatory obligations but serves as public notice of Siren Biotechnology's intent to use this mark.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
THE MARK CONSISTS OF OUR COMPANY NAME ‘SIREN BIOTECHNOLOGY’ WITH A STYLIZED DESIGN ELEMENT IN THE LETTER "E" OF SIREN, AND A STYLIZED FONT
Intent to Use TM99737013 Kind: intenttouse Apr 01, 2026
Abstract
Pharmaceutical preparations for gene therapy for the treatment of cancer; Research and development in the pharmaceutical and biotechnology fields
Filing Date
2026-03-31
Named provisions
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.